Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “AMGEN RES MUNICH GMBH [DE]”

1 pharma patents match "AMGEN RES MUNICH GMBH [DE]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 1 pharmaceutical patents matching "AMGEN RES MUNICH GMBH [DE]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1 result for “AMGEN RES MUNICH GMBH [DE]” · 30,257 patents in full index Clear search

  1. US 20260116972

    CROSS-SPECIES-SPECIFIC PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALINXCD3, EPCAMXCD3, IGF-1RXCD3 OR FAPALPHAXCD3 BISPECIFIC SINGLE CHAIN ANTIBODY

    AMGEN RES MUNICH GMBH [DE] · Granted Apr 30, 2026 · Expires Apr 25, 2046

    granted